Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-06 12:06 pm Purchase | 2025-06-30 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 51,002,622 13.900% | 10,846,867 (+27.01%) | Filing History |
| 2025-06-06 10:03 am Purchase | 2025-05-30 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 40,155,755 10.900% | 13,541,732 (+50.88%) | Filing History |
| 2025-02-14 09:44 am Sale | 2024-12-31 | 13G | Legend Biotech Corporation LEGN | T. Rowe Price Associates, Inc. | 6,808,081 3.700% | -4,357,503 (-39.03%) | Filing History |
| 2025-02-12 09:19 am Sale | 2024-12-31 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 26,614,023 7.300% | -9,766,415 (-26.85%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Legend Biotech Corporation LEGN | T. Rowe Price Associates, Inc. | 11,165,584 6.100% | 357,368 (+3.31%) | Filing History |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 36,380,438 9.999% | 10,784,450 (+42.13%) | Filing History |
| 2024-04-05 12:18 pm Purchase | 2024-03-31 | 13G | Legend Biotech Corporation LEGN | BlackRock Inc. BLK | 10,768,060 3.000% | 235,684 (+2.24%) | Filing History |
| 2024-02-14 8:34 pm Unchanged | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 47.990% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:40 pm Sale | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 13,052,732 3.600% | -7,220,502 (-35.62%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | T. Rowe Price Associates, Inc. | 10,808,216 5.900% | 10,808,216 (New Position) | Filing History |
| 2024-02-09 09:16 am Sale | 2024-02-08 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 25,595,988 7.040% | -7,417,460 (-22.47%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Legend Biotech Corporation LEGN | BlackRock Inc. BLK | 10,532,376 5.800% | 10,532,376 (New Position) | Filing History |
| 2023-05-10 09:45 am Purchase | 2023-05-09 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 33,013,448 9.999% | 2,730,292 (+9.02%) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 20,273,234 5.900% | -13,336,616 (-39.68%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | Zhang Fangliang | 1,067,386 0.320% | -31,207,218 (-96.69%) | Filing History |
| 2023-02-14 4:05 pm Sale | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | AquaPoint L.P. | 407,172 0.120% | -29,912,828 (-98.66%) | Filing History |
| 2023-02-14 4:02 pm Unchanged | 2022-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 52.120% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | Legend Biotech Corporation LEGN | FMR LLC | 30,283,156 9.227% | 30,283,156 (New Position) | Filing History |
| 2022-03-11 5:02 pm Purchase | 2021-12-31 | 13G | Legend Biotech Corporation LEGN | GenScript Biotech Corp | 174,497,556 57.100% | 4,500,000 (+2.65%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Legend Biotech Corporation LEGN | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 33,609,850 10.600% | 2,800,000 (+9.09%) | Filing History |